Overview: hypertension and atherosclerosis

Area of Science:

• Cardiovascular Science
• Pharmacology
• Vascular Biology

Background:

• Large-scale hypertension trials often show minimal benefit in preventing atherosclerosis complications.
• Understanding the precise mechanisms linking hypertension, its treatments, and atherosclerosis remains incomplete.
• Experimental models reveal hypertension-induced vascular changes, including endothelial and smooth muscle cell alterations.

Purpose of the Study:

• To explore the relationship between hypertension, antihypertensive drugs, and the development of atherosclerosis.
• To investigate the role of hypertension-induced vascular changes in atherogenesis.
• To assess the potential of certain antihypertensive drugs, like beta-blockers, in mitigating atherosclerosis.

Main Methods:

• Review of large-scale clinical trials on hypertension treatment.
• Analysis of experimental evidence, particularly animal models of hypertension.
• Examination of studies investigating the effects of beta-blockers in cholesterol-fed rabbit models.

Main Results:

• Hypertension alone may not accelerate atherosclerosis without elevated plasma lipid levels.
• Hypertension induces sequential changes in endothelial cells, smooth muscle cells, and endothelial permeability in animal models.
• Certain beta-blockers demonstrated a capacity to slow atherosclerosis progression in cholesterol-fed rabbits.

Conclusions:

• The direct impact of hypertension and its treatments on atherosclerosis pathogenesis requires further elucidation.
• Elevated plasma lipids are crucial for hypertension to accelerate atherosclerosis.
• Beta-blockers show promise in preclinical models, but clinical relevance needs further investigation.